Stockreport

Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024 [Yahoo! Finance]

Purple Biotech Ltd. - American Depositary Shares  (PPBT) 
PDF Potential biomarkers for treatment with NT219 detected in responding patients in Phase 1 REHOVOT, Israel, March 28, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Pur [Read more]